Clinical trial
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
NCT00223665 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00223665 |
|---|---|
| Title | Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer |
| Official title | A Prospective Study of Intermittent Androgen Suppression (IAS) in Men With Localized Prostate Cancer Who Have Biochemical Relapse After Radiation Therapy or Radical Prostatectomy |
| Acronym | IAS |
| Lead sponsor | University of Washington, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Flutamide, Leuprolide Acetate |
| Enrollment | 102 |
| Start date | Jan 8, 1997 |
| Primary completion | Sep 6, 2012 |
| Completion | Sep 6, 2012 |
| First posted | Sep 22, 2005 |
| Last update posted | Aug 7, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: